BiotechTube
Home/Pipeline/μCaler MRD Panel

μCaler MRD Panel

Minimal residual disease monitoring

CommercialActive

Key Facts

Indication
Minimal residual disease monitoring
Phase
Commercial
Status
Active
Company
Nanodigmbio

About Nanodigmbio

A Singapore‑based NGS diagnostics platform delivering ultra‑sensitive, rapid targeted sequencing solutions for oncology and infectious disease.

View full company profile

Therapeutic Areas

OncologyInfectious DiseasesGenetic DisordersHematologyImmunology

Other Minimal residual disease monitoring Drugs

DrugCompanyPhase
Precise MRDMyriad GeneticsDevelopment/Commercial